new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Laboratorios Del Dr Esteve S a patents

Recent patent applications related to Laboratorios Del Dr Esteve S a. Laboratorios Del Dr Esteve S a is listed as an Agent/Assignee. Note: Laboratorios Del Dr Esteve S a may have other listings under different names/spellings. We're not affiliated with Laboratorios Del Dr Esteve S a, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Laboratorios Del Dr Esteve S a-related inventors




Date Laboratorios Del Dr Esteve S a patents (updated weekly) - BOOKMARK this page
04/27/17Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy
04/13/17Alkyl and aryl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain
03/30/17Adenoassociated virus vectors for the treatment of lysosomal storage disorders
02/02/17Co-crystals of tramadol and coxibs
01/05/17Piperidine compounds having multimodal activity against pain
01/05/17Piperazine derivatives having multimodal activity against pain
01/05/17Oral pharmaceutical composition
01/05/17Co-crystals of tramadol and coxibs
10/27/16Fused imidazolyl derivatives, their preparation and use as medicaments
10/27/16Serotonin-norepinephrine reuptake inhibitors (snris) and sigma receptor ligands combinations
10/27/16Gabapentinoids and sigma receptor ligands combinations
08/04/16Nsaid and sigma receptor ligand combinations
08/04/16Sigma ligands for the prevention or treatment of pain induced by chemotherapy
07/14/16Sigma ligands for the prevention or treatment of pain induced by chemotherapy
06/30/161,2-disubstituted cyclobutyl compounds
06/02/16Use of sigma receptor ligands for the prevention and treatment of pain associated to interstitial cystitis/bladder pain syndrome (ic/bps)
03/17/16Pyrazino[1,2-a]indole compounds, their preparation and use in medicaments
03/03/16Alpha-2 adrenoceptor and sigma receptor ligand combinations
03/03/16Pyrazino[1,2-a]indole compounds, their preparation and use in medicaments
03/03/16Tricyclic triazolic compounds
12/10/15Substituted pyrano and furanoquinolines, their preparation and use as medicaments
12/10/151,2,3-triazole-4-amine derivatives for the treatment of sigma receptor related diseases and disorders
11/05/15Substituted pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma receptors ligands
08/20/15Methods for identifying hiv neutralizing antibodies
08/06/15Enhanced rapid immunogen selection hiv gp120 variants
07/30/15Mycobacterium comprising expression vector with two auxotrophic selection markers and its use as vaccine
07/16/15Co-crystals of tramadol and coxibs
07/16/15Co-crystals of tramadol and coxibs
06/18/15Controlled release formulation comprising mesalamine
06/18/15Imidazo[2,1-b]thiazole derivatives, their preparation and use as medicaments
06/11/15Indene derivatives, their preparation and use as medicaments
06/04/15Compositions comprising tramadol and celecoxib in the treatment of pain
05/07/15Method for the preparation of dendritic cell vaccines
02/26/15Method for monitoring hiv specific t cell responses
02/19/15Immunogens for hiv vaccination
01/29/15Oral pharmaceutical compositions of dabigatran etexilate
01/29/15Substituted pyrazolo[1,5-a]pyridines, their preparation and use as medicaments
01/29/15Substituted pyrano and furanoquinolines, their preparation and use as medicaments
01/15/151-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
01/08/15Method to identify ligands for sigma-1 receptors
12/18/14Inhibitors of sialoadhesin for the treatment of diseases caused by enveloped viruses
11/27/14Co-crystals of tramadol and nsaids
06/12/14Pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma ligands
05/29/14Methods and reagents for efficient control of hiv progression
04/17/14Use of sigma ligands in diabetes type-2 associated pain
02/27/14Co-crystals of tramadol and coxibs
02/06/14Rapid selection hiv gp-120 variants
01/23/14Compositions comprising tramadol and celecoxib in the treatment of pain
01/23/14Co-crystals of duloxetine and cox-inhibitors for the treatment of pain
12/05/13Use of sigma ligands in bone cancer pain
11/14/135-methyl-1-(naphthalen-2-yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
10/24/13Compressed solid dosage forms
06/20/13Sigma receptor inhibitors
06/20/13Use of sigma ligands in opioid-induced hyperalgesia
06/13/134-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
05/02/13Pharmaceutical compositions of co-crystals of tramadol and coxibs
05/02/13Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
03/21/13Bicyclic tetrahydropyrrole compounds
03/21/13Compositions comprising venlafaxine and celecoxib in the treatment of pain
01/31/13Co-crystals of venlafaxine and celecoxib
12/20/12Pharmaceutical composition of lansoprazole
12/20/12Heterocycyl-substituted-alkylaminophenyl derivatives, their preparation and use as medicaments
12/13/124-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
09/20/124,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
09/13/12Pyrazole derivatives as sigma receptor inhibitors
Patent Packs
07/05/12Compositions comprising tramadol and celecoxib in the treatment of pain
07/05/12Co-crystals of tramadol and coxibs
05/24/12Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity
03/15/12Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
03/08/12Sigma receptor inhibitors
01/05/121,2,4-triazole derivatives as sigma receptor inhibitors
11/17/11Imidazole compounds having pharmaceutical activity towards the sigma receptor
10/20/11Co-crystals of tramadol and nsaids
07/28/115ht7 receptor ligands and compositions comprising the same
07/21/11Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
07/14/112-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
06/30/11Pharmaceutical formulation comprising a cb1-receptor compound in a solid solution and/or solid dispersion
06/30/11Substituted pyrazoline compounds, their preparation and use as medicaments
05/26/11Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter
05/19/115-methyl-1-(naphthalen-2-yl)-1h-pyrazoles useful as sigma receptor inhibitors
Patent Packs
05/12/111-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
04/21/11Substituted n-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
03/24/11Process for the preparation of naphthalen-2-yl-pyrazol-3-one intermediates useful in the synthesis of sigma receptor inhibitors
03/03/11Indane-amine derivatives, their preparation and use as medicaments
02/03/114-methyl-4,5-dihydro-1h-pyrazole-3-carboxamide useful as a cannabinoid cb1 neutral antagonist
01/20/11Substituted pyrazole sigma receptor antagonists
01/06/11Rhodium-phosphorus complexes and their use in ring opening reactions
11/04/102-'4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
09/30/10Mechanical protective layer for solid dosage forms
09/09/10Salts of tramadol and naproxen and their crystal forms in the treatment of pain
08/19/10Process for the preparation of 6-substituted-imidazo [2,1-b] thiazole-5-sulfonyl halide
08/05/10Process for the enantioselective preparation of pregabalin
07/22/10Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
05/13/10Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
05/13/10Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
04/29/10Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
04/22/10Substituted pyrazoline compounds with acat inhibition activity
03/25/10Tetrodotoxin and its derivatives for the treament of peripheral-nervously derived neuropathi pain
03/25/10Combination of nmda-receptor ligand and a compound with 5-ht6 receptor affinity
03/25/10Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
03/18/10Substituted pyrazoline compounds with acat inhibition activity, their preparation and use as medicaments
03/18/10Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
02/11/10Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands
01/07/101,2,4-triazole derivatives as sigma receptor inhibitors
01/07/101,2,3-triazole derivatives as sigma receptor inhibitors
12/31/09Use of 5-ht7 receptor agonists for the treatment of pain
10/01/09Sigma receptor inhibitors
09/10/09Pyrazole derivatives as sigma receptors antagonists
09/03/094,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
08/20/09Substituted tetrahydroisoquinoline compound, their preparation and use in medicaments
Social Network Patent Pack
08/06/09Sigma receptor compounds
06/11/09Salts of substitutted pyrazoline compounds, their preparation and use and medicaments
05/21/09Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
02/26/09Octahydropentalene-substituted pyrazoline derivatives, their prepartion and use as medicaments







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Laboratorios Del Dr Esteve S a in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Laboratorios Del Dr Esteve S a with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';